Westover Capital Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,015
Closed -$227K 247
2024
Q3
$227K Hold
1,015
0.04% 228
2024
Q2
$207K Hold
1,015
0.05% 205
2024
Q1
$222K Hold
1,015
0.06% 170
2023
Q4
$231K Hold
1,015
0.08% 161
2023
Q3
$204K Sell
1,015
-166
-14% -$35K 0.07% 172
2023
Q2
$245K Hold
1,181
0.09% 157
2023
Q1
$233K Hold
1,181
0.09% 149
2022
Q4
$239K Hold
1,181
0.09% 135
2022
Q3
$208K Hold
1,181
0.08% 149
2022
Q2
$238K Sell
1,181
-67
-5% -$14.3K 0.09% 145
2022
Q1
$283K Hold
1,248
0.09% 151
2021
Q4
$337K Hold
1,248
0.1% 137
2021
Q3
$302K Hold
1,248
0.09% 139
2021
Q2
$296K Hold
1,248
0.1% 143
2021
Q1
$273K Sell
1,248
-8
-0.6% -$1.6K 0.09% 137
2020
Q4
$220K Buy
+1,256
New +$217K 0.08% 142

Other funds holding LH

Westover Capital Advisors's LH Position: Q4 2024 in Review

Westover Capital Advisors sold out of Labcorp (LH) in Q4 2024, closing a stake of 1,015 shares — an estimated $227K sold.

Westover Capital Advisors first reported a position in LH in Q4 2020 and held it in 16 quarters. The position peaked at $337K in Q4 2021. 926 funds tracked by Wall St. Rank hold LH as of Q4 2024.

  • Westover Capital Advisors reported no remaining Labcorp position as of Q4 2024 after selling out during the quarter.
  • Westover Capital Advisors sold 1,015 Labcorp shares in Q4 2024, an estimated $227K.
  • Westover Capital Advisors first reported a position in Labcorp in Q4 2020 and held it in 16 quarters.
  • Westover Capital Advisors's Labcorp position peaked at $337K in Q4 2021.
  • 926 funds tracked by Wall St. Rank held Labcorp as of Q4 2024.

Based on Westover Capital Advisors's 13F filing for Q4 2024, filed 6 Feb 2025.